Corporate Liability from Employee Diversion: Costly on Many Fronts
FDA Law Blog
JUNE 22, 2022
It was alleged that other employees administered the medication to patients even after observing signs of tampering, although no patients were reported harmed. The NPA requires “management” review of “any discrepancies discovered during an employee’s blind count when accessing controlled substances.”
Let's personalize your content